Table 1 Signalment of dogs enrolled as veterinary patients in studies conducted in Europe and the USA to evaluate the efficacy of Simparica Trio™ against natural gastrointestinal nematode infections
Signalment | European study (primary dogs) | USA study | ||
|---|---|---|---|---|
Simparica Trio™ (n = 194) | Afox + Milb (n = 97) | Simparica Trio™ (n = 120) | Ive + Pyr (n = 42) | |
Purebred | 76 | 39 | 71 | 25 |
Non-purebred | 118 | 58 | 49 | 17 |
Age, Mean (years) | 2.7 | 2.9 | 0.8 | 1.3 |
Age, Range (years) | 0.2–15.0 | 0.2–13.0 | 0.2–14.0 | 0.2–9.0 |
Body weight, Mean (kg) | 16.0 | 17.1 | 9.1 | 13.0 |
Body weight, Range (kg) | 2.1–70.0 | 2.1–51.0 | 1.5–47.4 | 1.5–39.8 |
Male | 108 | 49 | 65 | 21 |
Female | 86 | 48 | 55 | 21 |
Lives mostly indoors | 19 | 8 | 86 | 30 |
Lives mostly outdoors | 131 | 68 | 3 | 1 |
Lives indoors and outdoors | 44 | 21 | 31 | 11 |